Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation

Vasa - Journal of Vascular Diseases

Volumn 30, Issue 3, 2001, Pages 195-204

  Partsch, H ^a  

^a WILHELMINEN HOSPITAL   (Austria)

Author keywords

Ambulation; Compression; Deep vein thrombosis; HIT; Low molecular weight heparin; Pulmonary embolism

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BED REST; BLEEDING TENDENCY; DEATH; DEEP VEIN THROMBOSIS; FEMALE; HOSPITALIZATION; HUMAN; LEG COMPRESSION; LEG THROMBOSIS; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MOBILIZATION; THROMBOCYTOPENIA; WALKING;

EID: 0034853812     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.30.3.195     Document Type: Article

References (57)

1. A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis
2. Acute deep vein thrombosis: Early mobilization does not increase the frequency of pulmonary embolism
3. Leitlinien zur diagnostik und therapie der tiefen bein-beckenvenenthrombose
4. Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single-center study
5. Unerwartete proximale ausdehnung bei iliofemoralvenenthrombose
6. Out-of hospital treatment of venous thrombosis: Socioeconomic aspects and patient's quality of life
7. Incidence of the postthrombotic syndrome and the effects of compression stockings in patients with proximal venous thrombosis
8. Outpatient therapy with low-molecular-weight heparins: New perspectives for treatment of deep vein thrombosis
9. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
10. A meta-analysis comparing low-molecular-weight heparin with unfractionated heparin in the treatment of venous thromboembolism: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency
11. Eine neue therapie der phlebitis
12. Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: Subjective and economic aspects
13. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study)
14. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis
15. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials
16. Home treatment of deep vein thrombosis. A two-years experience of a single institution
17. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin
18. Undiagnosed malignancy in patients with deep vein thrombosis: Incidence, risk indicators, and diagnosis
19. Heparin treatment of deep venous thrombosis in 280 patients: Symptoms related to dosage
20. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis
21. The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects
22. Low-molecular-weight heparin versus heparin in the treatment of patients with pulmonary embolism
23. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis
24. 99mcTc-DTPA aerosol for same-day post-perfusion ventilation imaging: Results of a multicentre study
25. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
26. Outpatient treatment of pulmonary embolism with dalteparin
27. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: A meta-analysis
28. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis
29. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
30. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting
31. PHLECO: A multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery
32. Whole-blood immunoassay (SimpliRED®) versus plasma immunoassay (NycoCardTM) for the diagnosis of clinically suspected deep vein thrombosis
33. Secondary prevention of venous thromboembolism: A role for low-molecular-weight heparin
34. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis
35. Lungenembolie bei bein-beckenvenenthrombose: Ergebnisse einer prospektiven studie. Diagnostik, häufigkeit, nuklearmedizinisches und klinisches erscheinungsbild
36. Deep venous thrombosis and occult malignancy: An epidemiological study
37. Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis
38. Compression therapy of the legs
39. Compression and walking versus bed-rest in the treatment of proximal deep venous thrombosis with low-molecular-weight heparin
40. Venöse strömungsbeschleunigung in bein und becken durch anti-thrombose-strümpfe
41. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin
42. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once-or twice-daily low-molecular-weight heparin
43. Diagnose und therapie der tiefen venenthrombose
44. Die isotopenphlebographie mit anschließender lungenszintigraphie (markierte mikrosphären) bei akuter beckenvenenthrombose
45. Reporting standards in venous disease: An update
46. The clinical course of deep vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients
47. Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see?
48. Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism
49. Studies on the medical treatment of deep vein thrombosis
50. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
51. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
52. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism
53. Outpatient management of venous thromboembolism
54. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: A multicentre prospective randomised trial
55. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
56. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: A comparison of patient self-injection with home-care injection
57. Criteria for outpatient management of proximal lower extremity deep venous thrombosis